ArticleGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2026
Comparison of oncological outcomes between robotic and laparoscopic surgeries for gastric cancer: a multi-institutional cohort study in Japan.
Article in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe oncological safety and benefits of robotic gastrectomy (RG) in daily clinical practice remain unknown. This study aimed to compare 3-year outcomes between RG and laparoscopic gastrectomy (LG) for gastric cancer.
methodsThis multi-institutional retrospective cohort study was conducted in 19 Japanese hospitals and included patients with gastric cancer who underwent minimally invasive gastrectomy between January 2017 and December 2020. To balance baseline characteristics between patients who underwent RG and LG, 1:2 propensity score matching was conducted using 28 variables. The primary endpoint was 3-year relapse-free survival (RFS), with non-inferiority defined as the upper limit of 95% confidence interval (CI) for a hazard ratio (HR) of <1.33.
resultsIn this study, 3181 patients were included. After propensity score matching, 676 and 1352 patients from the RG and LG groups, respectively, were included in the analysis. In the matched cohort, RG was associated with longer operation time and less blood loss, whereas postoperative complications were comparable between the groups. Three-year RFS rate was 84.1% in the RG group and 84.3% in the LG group (HR, 1.02; 95% CI, 0.81-1.29; p = 0.873), indicating that RG met the criterion for non-inferiority to LG. The 3-year overall survival rate was 90.6% and 89.2% in the RG and LG groups, respectively (HR, 0.86; 95% CI, 0.64-1.17; p = 0.340). Subgroup analysis revealed that RG was associated with significantly better RFS in patients with pathological T4 disease (HR, 0.68; 95% CI, 0.47-0.99; p = 0.049).
conclusionsRG was not inferior to LG with respect to oncological outcomes.
Indexed as
Identifiers
42240715What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.